PembrolizumabCytokine release syndrome: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1939卷 / 1期

关键词：

D O I：

10.1007/s40278-023-31784-1

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：376 / 376

相关论文

共 50 条

[1] PembrolizumabCytokine release syndrome: case report
Reactions Weekly, 2024, 2023 (1) : 341 - 341
[2] PembrolizumabCytokine release syndrome: case report
Reactions Weekly, 2019, 1744 (1) : 219 - 219
[3] PembrolizumabCytokine release syndrome (First report): case report
Reactions Weekly, 2017, 1650 (1) : 224 - 224
[4] PembrolizumabCytokine release syndrome and haemophagocytic lymphohistiocytosis : case report
Reactions Weekly, 2021, 1870 (1) : 270 - 270
[5] Cefmetazole/PembrolizumabCytokine release syndrome and lack of efficacy: case report
Reactions Weekly, 2024, 2032 (1) : 121 - 121
[6] Gefitinib/osimertinib/pembrolizumabCytokine release syndrome and acquired drug resistance: case report
Reactions Weekly, 2022, 1909 (1) : 259 - 259
[7] PembrolizumabCytokine release syndrome and immune effector cell-associated neurotoxicity syndrome: case report
Reactions Weekly, 2024, 2028 (1) : 430 - 430
[8] TebentafuspCytokine release syndrome: case report
Reactions Weekly, 2024, 2028 (1) : 479 - 479
[9] TisagenlecleucelCytokine release syndrome: case report
Reactions Weekly, 2020, 1817 (1) : 302 - 302
[10] BlinatumomabCytokine release syndrome: case report
Reactions Weekly, 2016, 1605 (1) : 33 - 33

← 1 2 3 4 5 →